Global Drug-eluting Balloons Market Report 2023 to 2030

Global Drug-Eluting Balloons Market Analysis

$ 3999

Global drug-eluting balloons market valued at $1010.6 Mn in 2023, projected to reach $2747.8 Mn by 2030 with a 15.36% CAGR. The key drivers of the market include the increasing prevalence of cardiovascular conditions due to the aging population and lifestyle factors, expanding applications in healthcare for treating cardiovascular and peripheral vascular diseases, and advancements in balloon technology enhancing the efficacy, safety, and precision of drug-eluting balloons treatments. The Global Drug Eluting Balloons Market encompasses various key players across different therapeutic segments, including Bayer, Abbott, Medtronic, B. Braun, Boston Scientific, Eurocor, Aachen Resonance, Cook Medical, Acrostak, Terumo, among various others.

ID: IN10GLMD328 CATEGORY: Medical Devices GEOGRAPHY: Global AUTHOR: Dr. Netal Patel

Buy Now

Global Drug Eluting Balloons Market Analysis Executive Summary

Global drug-eluting balloons market valued at $1010.6 Mn in 2023, projected to reach $2747.8 Mn by 2030 with a 15.36% CAGR.

Drug-eluting balloons are conventional semi-compliant angioplasty balloons covered with an anti-proliferative drug that is released into the vessel wall during the inflation of the balloon. Drug-eluting balloons are used primarily in the treatment of coronary artery disease and peripheral arterial disease. They are designed to deliver a therapeutic drug to the target vessel at the site of atherosclerotic plaque or restenosis (narrowing of the blood vessel) to prevent re-narrowing after a balloon angioplasty procedure. Drug-eluting balloons are nowadays also being explored and used in other medical fields for the treatment of various conditions relating to gastroenterology and urology conditions, among others. These types of interventions deliver a high concentration of the drug directly to the target lesion, minimizing systemic exposure and reducing the risk of systemic side effects. Additionally, drug-eluting balloon procedures are typically less invasive than surgical interventions, making them a preferred option for many patients and potentially reducing hospital stay and recovery time.

The prevalence of cardiovascular diseases globally has been a significant health concern. These diseases, including heart attacks, strokes, atherosclerosis, and others, are the most common cause of death worldwide, responsible for a third of all deaths globally. More than 3 Mn percutaneous coronary interventions are performed worldwide annually. Cardiovascular disease has become a major problem with most cases happening in developed countries.

The key drivers of the market include the increasing prevalence of cardiovascular conditions due to the aging population and lifestyle factors, expanding applications in healthcare for treating cardiovascular and peripheral vascular diseases, and advancements in balloon technology enhancing the efficacy, safety, and precision of drug-eluting balloon treatments.

The drug-eluting balloons market is led by established medical device corporations like Medtronic, Boston Scientific, and Bayer. These companies leverage their strong brand recognition and history of innovation to capture a significant market share. They continuously invest in research and development to refine balloon technologies and expand their product lines, catering to a broader range of medical applications. Other established players like Terumo and Philips also hold a respectable presence in this market. There's a growing number of emerging companies with fresh perspectives and innovative ideas contributing to the market's growth.

Global Drug-Eluting Balloons Market Analyis 2023-2030

Market Dynamics

Market Growth Drivers

Increasing Prevalence of Cardiovascular Conditions: The global aging population is more susceptible to cardiovascular diseases. Drug-eluting balloons are used in the treatment of coronary artery disease, peripheral arterial disease, and other vascular conditions, making them a crucial tool in the management of these diseases. Other factors such as sedentary habits, changing eating patterns, and fast-paced lifestyles contribute to the significant burden of cardiovascular conditions.

Expanding Applications in Healthcare: The expanding applications of drug-coated balloons in healthcare, offering novel approaches to treat various persistent illnesses affecting the cardiovascular and peripheral vascular systems, are key drivers for market growth. These advancements make treating blood artery blockages more effective and less invasive, boosting the demand for these devices.

Advancements in Technology: Continuous advancements in balloon technology, including improved coatings and drug formulations, are driving the growth of the drug-eluting balloon market. Manufacturers are investing in research and development to enhance the efficacy and safety of Drug-eluting balloons, which is attracting both physicians and patients. Additionally, the integration of Drug-eluting balloons with imaging technologies such as intravascular ultrasound and optical coherence tomography allows for better visualization and precise delivery of the drug, thereby improving treatment outcomes.

Market Restraints

Alternative Treatment Options: With the continuous advancements in endovascular therapies, alternative treatment options such as atherectomy devices, drug-coated balloons, and drug-eluting stents continue to emerge. These alternative therapies can provide comparable or even superior results in certain patient populations, posing a challenge to the growth of the drug-eluting balloons market.

Potential Side Effects: Drug-eluting balloons can cause vascular complications such as dissection, perforation, or acute vessel closure, which may require additional interventions or surgical procedures to manage. Several case reports have suggested adverse effects in the form of vasculitis/panniculitis after drug-eluting balloons treatment for coronary artery disease and peripheral arterial disease. The potential side effects and safety concerns associated with Drug-eluting balloons can act as significant restraints in the global market.

Regulatory Challenges: Obtaining regulatory approvals for new drug-eluting balloon products can be a lengthy and costly process. Strict regulatory requirements and the need for extensive clinical trials can delay market entry and increase development costs for manufacturers.

Notable Recent Updates

October 2023, US-based Cordis, a leading interventional cardiovascular and endovascular technology developer and manufacturer, has acquired Swiss medical technology company MedAlliance for $1.135 Bn
September 2023, MedAlliance recently started enrolment of patients for a clinical trial in the UK for a novel sirolimus-eluting balloon that provides a controlled sustained release of the drug, similar to a drug-eluting stent

Competitive Landscape

Key Players

Bayer
Abbott
Medtronic
B. Braun
Boston Scientific
Eurocor
Aachen Resonance
Cook Medical
Acrostak
Terumo

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Global Drug Eluting Balloons Market Segmentation

By Disease Type

Coronary Artery Disease
Peripheral Artery Disease
Others

By End User

Hospitals & Ambulatory Care Centres
Cardio Care Centres
Others

By Region

North America
Europe
Asia Pacific
Latin America
Middle East and Africa

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.